Reuters logo
5 months ago
BRIEF-Jazz Pharma says gave Roxane non-exclusive license under Xyrem patents to produce generic sodium oxybate product
April 5, 2017 / 9:58 PM / 5 months ago

BRIEF-Jazz Pharma says gave Roxane non-exclusive license under Xyrem patents to produce generic sodium oxybate product

April 5 (Reuters) - Jazz Pharmaceuticals Plc

* Jazz Pharma - also gave Roxane non-exclusive license under Xyrem patents to make, market its generic sodium oxybate product under Roxane ANDA in Territory Source text: (bit.ly/2p2w878) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below